Literature DB >> 16289062

Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion.

Shelley Camp1, Limin Zhang, Michael Marquez, Brian de la Torre, Jeffery M Long, Goran Bucht, Palmer Taylor.   

Abstract

AChE is an alternatively spliced gene. Exons 2, 3 and 4 are invariantly spliced, and this sequence is responsible for catalytic function. The 3' alternatively spliced exons, 5 and 6, are responsible for AChE disposition in tissue [J. Massoulie, The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11 (3) (2002) 130-143; Y. Li, S. Camp, P. Taylor, Tissue-specific expression and alternative mRNA processing of the mammalian acetylcholinesterase gene. J. Biol. Chem. 268 (8) (1993) 5790-5797]. The splice to exon 5 produces the GPI anchored form of AChE found in the hematopoietic system, whereas the splice to exon 6 produces a sequence that binds to the structural subunits PRiMA and ColQ, producing AChE expression in brain and muscle. A third alternative RNA species is present that is not spliced at the 3' end; the intron 3' of exon 4 is used as coding sequence and produces the read-through, unanchored form of AChE. In order to further understand the role of alternative splicing in the expression of the AChE gene, we have used homologous recombination in stem cells to produce gene specific deletions in mice. Alternatively and together exon 5 and exon 6 were deleted. A cassette containing the neomycin gene flanked by loxP sites was used to replace the exon(s) of interest. Tissue analysis of mice with exon 5 deleted and the neomycin cassette retained showed very low levels of AChE expression, far less than would have been anticipated. Only the read-through species of the enzyme was produced; clearly the inclusion of the selection cassette disrupted splicing of exon 4 to exon 6. The selection cassette was then deleted in exon 5, exon 6 and exons 5 + 6 deleted mice by breeding to Ella-cre transgenic mice. AChE expression in serum, brain and muscle has been analyzed. Another AChE gene targeted mouse strain involving a region in the first intron, found to be critical for AChE expression in muscle cells [S. Camp, L. Zhang, M. Marquez, B. delaTorre, P. Taylor, Knockout mice with deletions of alternatively spliced exons of Acetylcholinesterase, in: N.C. Inestrosa, E.O. Campus (Eds.), VII International Meeting on Cholinesterases, Pucon-Chile Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects. P. Universidad Catholica de Chile-FONDAP Biomedicina, 2004, pp. 43-48; R.Y.Y. Chan, C. Boudreau-Larivière, L.A. Angus, F. Mankal, B.J. Jasmin, An intronic enhancer containing an N-box motif is required for synapse- and tissue-specific expression of the acetylcholinesterase gene in skeletal muscle fibers. Proc. Natl. Acad. Sci. USA 96 (1999) 4627-4632], is also presented. The intronic region was floxed and then deleted by mating with Ella-cre transgenic mice. The deletion of this region produced a dramatic phenotype; a mouse with near normal AChE expression in brain and other CNS tissues, but no AChE expression in muscle. Phenotype and AChE tissue activities are compared with the total AChE knockout mouse [W. Xie, J.A. Chatonnet, P.J. Wilder, A. Rizzino, R.D. McComb, P. Taylor, S.H. Hinrichs, O. Lockridge, Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293 (3) (2000) 896-902].

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289062     DOI: 10.1016/j.cbi.2005.10.012

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  ATP induces synaptic gene expressions in cortical neurons: transduction and transcription control via P2Y1 receptors.

Authors:  Nina L Siow; Roy C Y Choi; Heidi Q Xie; Ling W Kong; Glanice K Y Chu; Gallant K L Chan; Joseph Simon; Eric A Barnard; Karl W K Tsim
Journal:  Mol Pharmacol       Date:  2010-09-16       Impact factor: 4.436

2.  Contributions of selective knockout studies to understanding cholinesterase disposition and function.

Authors:  Shelley Camp; Limin Zhang; Eric Krejci; Alexandre Dobbertin; Véronique Bernard; Emmanuelle Girard; Ellen G Duysen; Oksana Lockridge; Antonella De Jaco; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-02-11       Impact factor: 5.192

Review 3.  Reassessment of the role of the central cholinergic system.

Authors:  Anna Hrabovska; Eric Krejci
Journal:  J Mol Neurosci       Date:  2013-11-10       Impact factor: 3.444

4.  Differential regulation of lipid metabolism genes in the brain of acetylcholinesterase knockout mice.

Authors:  Huang-Quan Lin; Yan Wang; Kam-Leung Chan; Tsz-Ming Ip; Chi-Cheong David Wan
Journal:  J Mol Neurosci       Date:  2014-02-27       Impact factor: 3.444

5.  Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit.

Authors:  Alexandre Dobbertin; Anna Hrabovska; Korami Dembele; Shelley Camp; Palmer Taylor; Eric Krejci; Véronique Bernard
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

6.  From Split to Sibenik: the tortuous pathway in the cholinesterase field.

Authors:  Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-05-20       Impact factor: 5.192

7.  Acetylcholinesterase expression in muscle is specifically controlled by a promoter-selective enhancesome in the first intron.

Authors:  Shelley Camp; Antonella De Jaco; Limin Zhang; Michael Marquez; Brian De la Torre; Palmer Taylor
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

Review 8.  Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase.

Authors:  Maria-Letizia Campanari; María-Salud García-Ayllón; Sorana Ciura; Javier Sáez-Valero; Edor Kabashi
Journal:  Front Mol Neurosci       Date:  2016-12-27       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.